1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Albumin Market


4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.4.4. Trends
4.5. Albumin Market Analysis and Forecast, 2016 – 2024
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Albumin Market - Global Supply Demand Scenario
4.7. Market Outlook
4.8. Porter’s five forces analysis


5. Global Albumin Market Analysis and Forecasts, By Product Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value (US$ Mn) Forecast By Product Type
5.4.1. Human Serum Albumin
5.4.2. Bovine Serum Albumin
5.4.3. Recombinant Albumin
5.5. Comparison Matrix
5.6. Market Attractiveness By Product Type


6. Global Albumin Market Analysis and Forecasts, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value (US$ Mn) Forecast By Application
6.4.1. Blood Volumizer
6.4.2. Drug Formulation and Vaccines
6.4.3. Life Sciences
6.4.4. Others
6.5. Comparison Matrix
6.6. Market Attractiveness By Application


7. Global Albumin Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Policies and Regulations
7.3. Market Value (US$ Mn) Forecast By Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Rest of the World
7.4. Market Attractiveness By Region


8. North America Albumin Market Analysis and Forecast
8.1. Introduction
8.2. Key Findings / Developments
8.3. Key Trends
8.4. Market Value (US$ Mn) Forecast By Product Type
8.4.1. Human Serum Albumin
8.4.2. Bovine Serum Albumin
8.4.3. Recombinant Albumin
8.5. Market Value (US$ Mn) Forecast By Application
8.5.1. Blood Volumizer
8.5.2. Drug Formulation and Vaccines
8.5.3. Life Sciences
8.5.4. Others
8.6. Market Size (US$ Mn) Forecast, By Country
8.6.1. U.S.
8.6.2. Canada
8.7. Market Attractiveness Analysis
8.7.1. By Product Type
8.7.2. By Application
8.7.3. By Country


9. Europe Albumin Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings / Developments
9.3. Key Trends
9.4. Market Value (US$ Mn) Forecast By Product Type
9.4.1. Human Serum Albumin
9.4.2. Bovine Serum Albumin
9.4.3. Recombinant Albumin
9.5. Market Value (US$ Mn) Forecast By Application
9.5.1. Blood Volumizer
9.5.2. Drug Formulation and Vaccines
9.5.3. Life Sciences
9.5.4. Others
9.6. Market Size (US$ Mn) Forecast, By Country
9.6.1. Germany
9.6.2. U.K.
9.6.3. France
9.6.4. Spain
9.6.5. Italy
9.6.6. Rest of Europe
9.7. Market Attractiveness Analysis
9.7.1. By Product Type
9.7.2. By Application
9.7.3. By Country


10. Asia Pacific Albumin Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings / Developments
10.3. Key Trends
10.4. Market Value (US$ Mn) Forecast By Product Type
10.4.1. Human Serum Albumin
10.4.2. Bovine Serum Albumin
10.4.3. Recombinant Albumin
10.5. Market Value (US$ Mn) Forecast By Application
10.5.1. Blood Volumizer
10.5.2. Drug Formulation and Vaccines
10.5.3. Life Sciences
10.5.4. Others
10.6. Market Size (US$ Mn) Forecast, By Country
10.6.1. Japan
10.6.2. China
10.6.3. India
10.6.4. Australia & New Zealand
10.6.5. Rest of Asia Pacific
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Application
10.7.3. By Country


11. Rest of the World Albumin Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings / Developments
11.3. Key Trends
11.4. Market Value (US$ Mn) Forecast By Product Type
11.4.1. Human Serum Albumin
11.4.2. Bovine Serum Albumin
11.4.3. Recombinant Albumin
11.5. Market Value (US$ Mn) Forecast By Application
11.5.1. Blood Volumizer
11.5.2. Drug Formulation and Vaccines
11.5.3. Life Sciences
11.5.4. Others
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application


12. Competition Landscape
12.1. Market Player – Competition Matrix (By Tier and Size of companies)
12.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
12.2.1. CSL Behring LLC
12.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.1.2. Product Portfolio
12.2.1.3. SWOT Analysis
12.2.1.4. Financial Overview
12.2.1.5. Strategic Overview
12.2.2. GRIFOLS INTERNATIONAL, S.A.
12.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.2.2. Product Portfolio
12.2.2.3. SWOT Analysis
12.2.2.4. Financial Overview
12.2.2.5. Strategic Overview
12.2.3. Shire Plc. (Baxalta Inc.)
12.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.3.2. Product Portfolio
12.2.3.3. SWOT Analysis
12.2.3.4. Financial Overview
12.2.3.5. Strategic Overview
12.2.4. Octapharma AG
12.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.4.2. Product Portfolio
12.2.4.3. SWOT Analysis
12.2.4.4. Financial Overview
12.2.4.5. Strategic Overview
12.2.5. InVitria
12.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.5.2. Product Portfolio
12.2.5.3. SWOT Analysis
12.2.5.4. Financial Overview
12.2.5.5. Strategic Overview
12.2.6. Kedrion S.p.A
12.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.6.2. Product Portfolio
12.2.6.3. SWOT Analysis
12.2.6.4. Financial Overview
12.2.6.5. Strategic Overview
12.2.7. HiMedia Laboratories
12.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.7.2. Product Portfolio
12.2.7.3. SWOT Analysis
12.2.7.4. Financial Overview
12.2.7.5. Strategic Overview
12.2.8. Medxbio Pte Ltd
12.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.8.2. Product Portfolio
12.2.8.3. SWOT Analysis
12.2.8.4. Financial Overview
12.2.8.5. Strategic Overview
12.2.9. Mitsubishi Tanabe Pharma Corporation
12.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.9.2. Product Portfolio
12.2.9.3. SWOT Analysis
12.2.9.4. Financial Overview
12.2.9.5. Strategic Overview
12.2.10. Albumedix A/S
12.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.10.2. Product Portfolio
12.2.10.3. SWOT Analysis
12.2.10.4. Financial Overview
12.2.10.5. Strategic Overview
12.2.11. Sigma-Aldrich Co. LLC.
12.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.11.2. Product Portfolio
12.2.11.3. SWOT Analysis
12.2.11.4. Financial Overview
12.2.11.5. Strategic Overview
12.2.12. Thermo Fisher Scientific Inc.
12.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
12.2.12.2. Product Portfolio
12.2.12.3. SWOT Analysis
12.2.12.4. Financial Overview
12.2.12.5. Strategic Overview


13. Key Take Away